Articles|  App notes / Features / Science success stories / Interviews / White papers

Microbiota from young mice reversed some aspects of aging and enhanced brain health in aged mice.

Centenarians have distinct microbiomes with species that produce unique bile acids, which may help thwart illness.

Scientists added a gene circuit that senses and neutralizes proinflammatory ATP to yeast, taking another step towards precision medicine.

Synthetic biologists introduced an engineered microbe that may lead to new treatment options for phenylketonuria.

A device smaller than two stacked decks of cards can reliably detect and discriminate between SARS-CoV-2 variants in spit in less than an hour with results that glow.

Researchers are taking the concept of three-dimensional cell culture beyond single organoids to develop embryos from cells.

An unusual drug screen takes advantage of “porcupine-like” structures of cancer cells in 3D organoids.

Pradipta Ghosh has plans to revolutionize the drug discovery pipeline.

An unfolded protein found in human milk shows promise in early clinical trials to treat bladder cancer.

A clever approach to modifying already existing cancer therapies may be a game changer for treating metastatic breast cancer.

An unexpected and unprecedented finding may lead to improved cancer therapies.

Glucometers are easy-to-use, cheap, and highly scalable. And they are 100 percent accurate at detecting SARS-CoV-2.

Tiny but powerful nanobodies may be the innovation that snuffs out the pandemic.

Skin symptoms are often the first, or only, symptom of COVID-19.

Transplanted CAR stem cells persisted long term and showed multilineage engraftment in tissues that harbor HIV.

Researchers developed a new CAR T-cell therapy that targets specific growth factor receptors in glioblastoma to eliminate brain tumors.

Pairing CARs with a synthetic receptor makes T cells more lethal tumor killers.

Scientists in cannabis extraction laboratories are bravely pioneering a new field of agro-chemical engineering.

Scientists uncover the promise of mesenchymal stem cells (MSCs), also known as medicinal signaling cells, to modulate the immune system and regenerate tissue.

A conversation with Dirk Ahlbrecht from Sartorius about where lab balance technology is headed in the 21st century